Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits

Kristen Jackson, Kendall F. Moseley

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits'. Together they form a unique fingerprint.

Medicine & Life Sciences